Buy the full study
Detailed content of our market study
Inforamtion
- Number of pages : ~ 40 pages
- Format : Digital and PDF versions
- Last update :
Summary and extracts
1 Market Summary
1.1 Definition and presentation
The aesthetic medicine and surgery market includes two different segments:
- Aestheticmedicine: a less invasive branch that does not use surgery to correct a patient's blemishes or defects. Aesthetic medicine treatments are characterized by noninvasive treatments and usually short and painless recovery times.
- Cosmetic surgery: a branch of plastic surgery that allows a patient's appearance to be improved or physical defects to be permanently eliminated, either totally or partially, through surgeries. Cosmetic surgery procedures are quite invasive, in most cases produce permanent results, and involve longer and more painful recovery times.
This market study focuses mainly on the first segment.
The global cosmetic surgery and medicine market is growing rapidly, and is expected to grow at a CAGR of 11% through 2027. The aesthetic medicine market still remains predominantly dominated by the United States, where a record 5.3 million non-surgical procedures were performed in 2021.
The Italian market is also growing, thanks in particular to the increasing popularity of so-called "non-invasive" methods of aesthetic medicine, placed on the borderline between medical treatment and simple aesthetic procedures. Italy is in fact the country in the world with the highest number of aesthetic medicine procedures in proportion to its population. In recent years, due to covid, this growth has come to a halt from which Italy is recovering more slowly than other countries.
The Italian market is still predominantly driven by women, with 75.8% of procedures, but interest from men has grown in recent years. In fact, it is estimated that requests for non-surgical treatments by men have increased by 25.4 percent since 2008 .
Italians are resorting to aesthetic medicine from an increasingly younger age, as they prefer to prevent the signs of aging, instead of treating them, in the best possible way and with optimal results.
In Italy, the injectables segment dominates the aesthetic medicine market, with 79.8% of all procedures. In fact, Hyaluronic acid fillers and botulinum toxin are the most popular nonsurgical procedures among Italians.
The aesthetic medicine market requires high entry costs and advanced technology , and most manufacturers specialize in manufacturing. The market is constantly renewing, and in recent years there have been major technological advances that have enabled the spread of increasingly less invasive and more effective procedures, such as CoolSculpting and Rhinofiller .
1.2 The global market driven by the United States
The aesthetic medicine and surgery market consists of two segments:
aesthetic medicine (***) cosmetic surgery (***)
The global aesthetic medicine and surgery market was valued at $**.* billion in **** and is expected to grow at a CAGR of **% through ****, reaching a value of $**.* billion at the end of the period.
Market growth is encouraged ...
1.3 Domestic market
According to ISAPS, the Italian market represents *.*% of the global aesthetic medicine and surgery market, which gives us an Italian market size of ***.** million euros (***)
In Italy, the aesthetic medicine segment is one of the most developed in the world, accounting for **.* of the total market. Therefore, we can estimate the ...
1.4 The rise of medical tourism
Medical tourism refers to the phenomenon whereby patients travel abroad to undergo medical treatment. In the past, this term usually referred to those who traveled from developing countries to major medical centers in more developed countries to undergo treatment to which they would not have access in their own country. However, ...
1.5 The impact of Covid
The impact of COVID-** on the aesthetic medicine sector in Italy was significant. Compared to the global average, Italy had a higher percentage of temporarily closed clinics (***). Other consequences include reduced clinic hours, decreased demand for aesthetic treatments due to both safety and virus concerns and loss of income, and increased ...
2 Demand analysis
2.1 Demand remains confined to a small part of the population
Demographics of demand
In Italy, demand for aesthetic medicine treatments has been growing steadily for several decades, thanks to several socio-demographic factors such as an aging population, the increasing importance of physical appearance, the normalization of aesthetic treatments, and the expansion of the male market. As we have seen, the sector ...
2.2 The reasons why Italians turn to cosmetic medicine
The main reason why men and women decide to undergo aesthetic medicine surgery is the need to feel good about themselves: almost * out of ** patients (***) stated this. An interesting fact that reflects the change in our society in recent years is the one related to the importance of image on social ...
2.3 Demand trends
The needs and demands of Italians have changed profoundly in recent years, redefining the existing dynamics within the world of aesthetic medicine and surgery.
There are three main trends in demand: the influence of social media on young people who choose to resort to aesthetic medicine, the growing focus on the ...
2.4 The impact of the Covid-19 emergency on demand
The lockdown caused by the Covid-** pandemic has generated a renewed interest in self-care among Italians. After months of carbohydrate-rich diets, lack of exposure to the sun and outdoors, accumulated stress and the effect of blue light from screens, Italians began to see the effects of the pandemic on their skin. ...
3 Market structure
3.1 A market structured around equipment manufacturers and medical professionals
The value chain of aesthetic medicine includes several stages. First, raw materials are supplied to manufacturers, who process them to produce medical equipment. The latter is then purchased by independent medical practices, hospitals, and aesthetic medicine centers, and is finally used to perform nonsurgical procedures on final patients.
We can distinguish ...
3.2 Production of aesthetic medicine equipment
Aesthetic equipment manufacturing includes the production of injectables, energy-based machinery, and cosmeceuticals. The aesthetics market requires high entry costs and advanced technology , and most manufacturers specialize in producing one of these segments.
The main players in the market international companies, and most production sites are located abroad with the exception of ...
3.3
4 Supply analysis
4.1 Overview of the offer
The supply in the aesthetic medicine market can be summarized as follows:
*. Injectables
Botulinum toxin : Botulinum toxin works by inhibiting the release of the neurotransmitter acetylcholine: by blocking its release in the muscles, it reduces excessive facial expressions and thus stops skin sagging, the primary cause of wrinkles and stretch ...
4.2 Injectables segment leading the market
In Italy, the injectables segment dominates the aesthetic medicine market, accounting for **.*% of all procedures. In contrast, facial rejuvenation and other procedures account for only a marginal share of the market, *.*% and **.*%, respectively.
Distribution of the aesthetic medicine market by macro segment Italy, ****, in % Source: ****
Analyzing the distribution of the injectables ...
4.3 Characteristics and prices of procedures
The following table summarizes the characteristics of commercially available nonsurgical aesthetic procedures:
Source: ****
it is important to note that prices vary widely depending on the medical facility, physician, or region.
4.4 Supply trends
The aesthetic medicine market has undergone profound changes in recent years that have been driven by changing customer demand. The supply has adapted to these trends by developing new techniques or advanced machines. Thanks to the continuous technological research conducted by market players, procedures are increasingly dynamic and allow for effective, ...
5 Rules and regulations
5.1 Italian regulations
Title required to perform aesthetic medicine treatments
The aesthetic physician has a degree in Medicine and Surgery , but it is not essential that he or she have any other type of specialization. There is not yet an EEC-compliant University Postgraduate School for aesthetic medicine, and therefore there is not yet a ...
5.2 Off-label prescribing
Any pharmaceutical company that introduces a new drug to the market must have approval from its relevant ministry. The drug is authorized for the particular clinical indication required, calling it "on label." A physician who uses a drug outside of its usual use, uses it out of indication or "off label." ...
6 Positioning of actors
6.1 Segmentation
- Fidia Farmaceutici
- Decomedical
- ITS Group
- BTL
- EME Estetica
- Ipsen
- Merz Pharmaceuticals
- Allergan plc (Abbvie)
List of charts presented in this market study
- Valore del mercato Europeo di medicina estetica
- Trend of the number of surgical and non-surgical procedures.
- Valore mercato globale della medicina estetica
- Tipologia di prodotti utilizzati nella medicina estetica
- Ripartizione del valore del mercato globale della medicina estetica
All our studies are available online in PDF format
Take a look at an example of our research on another market!
Latest news
Ipsen's commitment to the area of rare diseases - 29/02/2024
Performance and strategies of the biopharmaceutical company Ipsen in 2023: 1. **Increase in sales:** In 2023, Ipsen recorded an increase in global sales of 3.4% over the previous year. 2. **Operating margin:** The company recorded an operating margin of 26.1%, which shows an increase of 2% compared to 2022. 3. **Growth factors:** Growth was supported by the company's historical assets, new drugs, pipeline expansion, and accelerated investment in research and development, particularly benefited by recent acquisitions focused on the area of rare diseases. 4. **Entry into the rare disease area:** In 2023, Ipsen acquired Albireo, a leading developer of bile acid modulators for the treatment of pediatric and adult cholestatic liver disease, bringing odevixibat, the first approved treatment against progressive familial intrahepatic cholestasis (Pfic), to the market. 5. **Future Plans:** By 2024, Ipsen plans to launch four innovative therapies worldwide and expand its pipeline, supported by an external innovation strategy in its three core therapeutic areas. 6. **Rare disease commitment:** With new developments such as odevixibat and an evolving pipeline, Ipsen marks its official entry into the rare disease field, aiming to bring therapeutic innovations that can change the course of disease, with a focus on drugs with novel mechanisms of action.
Botox: botulinum toxin boosts pharma's bottom line - 02/08/2023
- The United States accounts for half of the global botulinum toxin market.
- Last year, Botox accounted for $5.2 billion in worldwide sales for AbbVie, with equal shares between aesthetics (+21% excluding currency effect) and therapeutics (+13%).
- In the United States, Dysport (Ipsen) has only 5% of the therapeutic market, compared with 30% in France.
- In aesthetics in the US, Ipsen has an estimated share of between 20% and 25%.
- Of the French laboratory Ipsen's half-year sales of 1.5 billion euros (+7%), 319 million (+32%) come from botulinum toxin sold in therapeutics and, in some countries, in aesthetics.
- Botox holds 40% to 50% of the therapeutic market in France, compared with 30% for Ipsen.
Medicine, Allergan Aesthetics launches training center for healthcare professionals - 26/06/2023
Inauguration of Allergan Aesthetics' Center of Excellence in Italy, specifically in Rome. This center represents the first and only space completely dedicated to both theoretical and practical training of healthcare professionals. Its foundation is supported by the expertise of a multidisciplinary scientific committee composed of 21 nationally and internationally renowned experts. The main goal of the center is to offer high-quality training to healthcare professionals through 4 complementary curricula in order to ensure maximum satisfaction of their patients.
Ipsen exceeds its targets, helped by its Botox competitor - 11/02/2023
- Family-owned laboratory controlled by descendants of Henri Beaufour
- Ipsen exceeds its targets
- Strong growth in sales of Dysport, its botulinum toxin competitor to Botox, generating €594 million in sales
Ipsen bets $1 billion on a biotech to treat liver disease - 21/01/2023
- Ipsen announces largest acquisition since the sale of Smecta (its family healthcare division) in 2022
- french pharmaceutical group to launch $952 million takeover bid for US biotech Albireo
- By 2021, Ipsen has added 16 new molecules to its portfolio
Ipsen strengthens its position in the dynamic rare diseases segment - 09/01/2023
- Ipsen to pay €1 billion for US biotech Albireo
- The market for rare diseases is close to $150 billion
Companies quoted in this study
This study contains a complete overview of the companies in the market, with the latest figures and news for each company. :
Choosing this study means :
Access to more than 35 hours of work
Our studies are the result of over 35 hours of research and analysis. Using our studies allows you to devote more time and added value to your projects.
Benefit from 6 years' experience and over 1,500 industry reports already produced
Our expertise enables us to produce comprehensive studies in all sectors, including niche and emerging markets.
Our know-how and methodology enable us to produce reports that offer unique value for money.
Access to several thousand articles and paid-for data
Businesscoot has access to all the paid economic press as well as exclusive databases to carry out its market research (over 30,000 articles and private sources).
To enhance our research, our analysts also use web indicators (semrush, trends, etc.) to identify market trends and company strategies. (Consult our paying sources)
Guaranteed support after your purchase
A team dedicated to after-sales service, to guarantee you a high level of satisfaction. +44 238 097 0676
A digital format designed for our users
Not only do you have access to a PDF, but also to a digital version designed for our customers. This version gives you access to sources, data in Excel format and graphics. The content of the study can therefore be easily retrieved and adapted for your specific needs.
Our offers :
the aesthetic medicine market | Italy
- What are the figures on the size and growth of the market?
- What is driving the growth of the market and its evolution?
- What is the positioning of companies in the value chain?
- Data from several dozen databases
5 reports pack (-15%) IT Italy
- 5 reports at €75.6 excluding VAT per study to choose from our Italian catalogue for 12 months
- Save 15% on additional studies purchased
- Choose to be refunded any unused credit at the end of the 12-month period (duration of the pack)
See the terms and conditions of the pack and the refund of unused credit.
Our customer references
They have consulted our studies
Discover the opinions (+500)
Malcolm Vincent
Astoria Finance
Gregoire de Castelnau
Stags Participations
Timothé Huignard
PWC
Paul-Alexis Kebabtchieff
BCG
Aymeric Granet
Publicis Consultant
interviews & case studies
All interviews and case studies (45)
